Profil
Inaba Taro is a managing partner and managing director at Remiges Ventures Inc., a company he founded in 2014.
He is also currently a director at Capacity Bio, Inc. In the past, he worked as a general manager at Mitsui & Co., Ltd. from 2009 to 2014.
Mr. Taro received his undergraduate degree from Kyoto University in 1991 and his MBA from the European University at Saint Petersburg in 1995.
Aktive Positionen von Inaba Taro
| Unternehmen | Position | Beginn |
|---|---|---|
Remiges Ventures Inc.
Remiges Ventures Inc. Investment ManagersFinance Remiges Ventures invests in companies globally. The firm focuses in the field of therapeutics. It participates in financing for seed, early, and later capital requirements. The firm leads transactions. | Gründer | 01.06.2014 |
Capacity Bio, Inc.
Capacity Bio, Inc. BiotechnologyHealth Technology Engages in targeting fundamental biology for radical therapeutic benefits | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Inaba Taro
| Unternehmen | Position | Ende |
|---|---|---|
| MITSUI & CO., LTD. | Corporate Officer/Principal | 01.05.2014 |
Ausbildung von Inaba Taro
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Mitsui & Co., Ltd.
Mitsui & Co., Ltd. Chemicals: Major DiversifiedProcess Industries Manufactures chemicals and engages in the sale, import, export of industrial materials, raw iron, nonferrous metal, chemical, energy and food | Process Industries |
Kyoto University
Kyoto University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European University at Saint Petersburg
European University at Saint Petersburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Remiges Ventures Inc.
Remiges Ventures Inc. Investment ManagersFinance Remiges Ventures invests in companies globally. The firm focuses in the field of therapeutics. It participates in financing for seed, early, and later capital requirements. The firm leads transactions. | Finance |
Capacity Bio, Inc.
Capacity Bio, Inc. BiotechnologyHealth Technology Engages in targeting fundamental biology for radical therapeutic benefits | Health Technology |
















